1. Sobel J. Botulism. Clinical Infectious Diseases. 2005 Oct 15;41(8):1167–73.
2. Kerner J. Neue Beobachtungen uber die in Wurtemburg so haufig vorfallen Vergiftung durch den Genuss gerauchter Wurst. Tubingen, 1820. In: Damon SR, editor. In: Food Infections and
Food Intoxications. Baltimore; 1928. p. 67.
3. Jankovic J, Schwartz KS. Clinical Correlates of Response to Botulinum Toxin Injections. Arch Neurol. 1991 Dec 1;48(12):1253–6.
4. Ayşe Willke Topçu, Güner Söyletir, Mehmet Doğanay. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. 3rd ed. Ayşe Willke Topçu, editor. istanbul: Nobel Tıp Kitabevleri; 2008. 1477–1483 p.
5. Chia JK, Clark JB, Ryan CA, Pollack M. Botulism in an Adult Associated with Food-Borne Intestinal Infection with Clostridium botulinum. New England Journal of Medicine. 1986 Jul
24;315(4):239–41.
6. FDA. (2021, February 2). Highlights of prescribing information: BOTOX (onabotulinumtoxinA) for injection, intramuscular. Available at: www.fda.gov/medwatch.
7. Scott AB. Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery. Ophthalmology. 1980 Oct;87(10):1044–9.
8. Rawson AM, Dempster AW, Humphreys CM, Minton NP. Pathogenicity and virulence of Clostridium botulinum. Virulence. 2023 Dec 31;14(1).
9. Pengram, P. S., & Stone, S. M. (2023). Botulismus. UpToDate. https://www.uptodate.com/contents/botulism.
10. Torrey, B., Birch, T. P. B. (2020). Botulism. In G. L. Mandell, J. E. Bennett, & R. Dolin (Eds.), Principles and Practice of Infectious Diseases (9th ed., pp. 2954–2959). Philadelphia: Elsevier-C-
hurchill Livingstone.
11. Arnon SS, Schechter R, Inglesby T V., Henderson DA, Bartlett JG, Ascher MS, et al. Botulinum Toxin as a Biological Weapon. JAMA. 2001 Feb 28;285(8):1059.
12. WHO, Botulism. (2024). https://www.who.int/news-room/fact sheets/detail/botulism, 25 September 2023
13. Fagan RP, McLaughlin JB, Castrodale LJ, Gessner BD, Jenkerson SA, Funk EA, et al. Endemic Foodborne Botulism among Alaska Native Persons–Alaska, 1947-2007. Clinical Infectious
Diseases. 2011 Mar 1;52(5):585–92.
14. Rao AK, Walters M, Hall J, Guymon C, Garden R, Sturdy P, et al. Outbreak of Botulism Due to Illicit Prison-Brewed Alcohol: Public Health Response to a Serious and Recurrent Problem.
Clinical Infectious Diseases. 2018 Jan 1;66(suppl_1):S85–91.
15. Gao QY, Huang YF, Wu JG, Liu HD, Xia HQ. A review of botulism in China. Biomed Environ Sci. 1990 Sep;3(3):326–36.
16. National Botulism Surveillance Summary, 2018. (2024, May 3). https://www.cdc.gov/botulism/php/national-botulism-surveillance/2018.html.
17. National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Centers for Disease Control and Prevention: Botulism. (2024, April 18). https://www.cdc.gov.
18. Davis JB. CLOSTRIDIUM BOTULINUM IN A FATAL WOUND INFECTION. J Am Med Assoc. 1951 Jun 16;146(7):646.
19. Kalka-Moll WM, Aurbach U, Schaumann R, Schwarz R, Seifert H. Wound botulism in injection drug users. Emerg Infect Dis. 2007 Jun;13(6):942–3.
20. Mechem CC, Walter FG. Wound botulism. Vet Hum Toxicol. 1994 Jun;36(3):233–7.
21. Roblot F, Popoff M, Carlier JP, Godet C, Abbadie P, Matthis S, et al. Botulism in Patients Who Inhale Cocaine: The First Cases in France. Clinical Infectious Diseases. 2006 Sep;43(5):e51–2.
22. M’ikanatha NM, Southwell B, Lautenbach E. Automated Laboratory Reporting of Infectious Diseases in a Climate of Bioterrorism. Emerg Infect Dis. 2003 Sep;9(9):1053–7.
23. Rao AK, Lin NH, Jackson KA, Mody RK, Griffin PM. Clinical Characteristics and Ancillary Test Results Among Patients With Botulism—United States, 2002–2015. Clinical Infectious Dise-
ases. 2018 Jan 1;66(suppl_1):S4–10.
24. Witmanowski H, Błochowiak K. The whole truth about botulinum toxin – a review. Advances in Dermatology and Allergology. 2020;37(6):853–61.
25. European Centre for Disease Prevention and Control. (2023, April). Update on iatrogenic botulism cases in Europe. ECDC. https://www.ecdc.europa.eu
26. Değerli V, Akarca FK, Özmen G, Barbaros S. Acil serviste atlanan olgular: Botulizm. İzmir Atatürk Eğitim Hastanesi Tıp Dergisi. 2009;47:167–9.
27. Bleck TP, Brauner JS. Tetanus. In: Scheld WM WRMCM, editor. Infections of the Central Nervous System. 3rd ed. New York; : Lippincott Williams and Wilkins; 2004. p. 625–48.
28. Trimble WS, Cowan DM, Scheller RH. VAMP-1: a synaptic vesicle-associated integral membrane protein. Proceedings of the National Academy of Sciences. 1988 Jun;85(12):4538–42.
29. Rao AK, Lin NH, Jackson KA, Mody RK, Griffin PM. Clinical Characteristics and Ancillary Test Results Among Patients With Botulism—United States, 2002–2015. Clinical Infectious Dise-
ases. 2018 Jan 1;66(suppl_1):S4–10.
30. Chatham-Stephens K, Fleck-Derderian S, Johnson SD, Sobel J, Rao AK, Meaney-Delman D. Clinical Features of Foodborne and Wound Botulism: A Systematic Review of the Literature,
1932–2015. Clinical Infectious Diseases. 2018 Jan 1;66(suppl_1):S11–6.
31. Terranova W, Palumbo JN, Breman JG. Ocular findings in botulism type B. JAMA. 1979 Feb 2;241(5):475–7.
32. Vita G. Cardiovascular-Reflex Testing and Single-Fiber Electromyography in Botulism. Arch Neurol. 1987 Feb 1;44(2):202.
33. Glauser TA, Maguire HC, Sladky JT. Relapse of infant botulism. Ann Neurol. 1990 Aug 8;28(2):187–9.
34. Chertow DS, Tan ET, Maslanka SE, Schulte J, Bresnitz EA, Weisman RS, et al. Botulism in 4 Adults Following Cosmetic Injections With an Unlicensed, Highly Concentrated Botulinum Pre-
paration. JAMA. 2006 Nov 22;296(20):2476.
35. Rao AK, Lin NH, Griese SE, Chatham-Stephens K, Badell ML, Sobel J. Clinical Criteria to Trigger Suspicion for Botulism: An Evidence-Based Tool to Facilitate Timely Recognition of Suspe-
cted Cases During Sporadic Events and Outbreaks. Clinical Infectious Diseases. 2018 Jan 1;66(suppl_1):S38–42.
36. Dunbar EM. Botulism. Journal of Infection. 1990 Jan;20(1):1–3.
37. Zhang Y, Lou J, Jenko KL, Marks JD, Varnum SM. Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein
antibody microarrays. Anal Biochem. 2012 Nov;430(2):185–92.
38. Satterfield BA, Stewart AF, Lew CS, Pickett DO, Cohen MN, Moore EA, et al. A quadruplex real-time PCR assay for rapid detection and differentiation of the Clostridium botulinum toxin
genes A, B, E and F. J Med Microbiol. 2010 Jan 1;59(1):55–64.
39. Baysallar M. Botulizm ve tanısal yaklaşım. TAF Prev Med Bull. 2011;(10):343–50.
40. Caya JG, Agni R, Miller JE. Clostridium botulinum and the Clinical Laboratorian: A Detailed Review of Botulism, Including Biological Warfare Ramifications of Botulinum Toxin. Arch Pathol
Lab Med. 2004 Jun 1;128(6):653–62.
41. Vealan K, Joseph N, Alimat S, Karumbati AS, Thilakavathy K. Lateral flow assay: a promising rapid point-of-care testing tool for infections and non-communicable diseases. Asian Biomedi-
cine. 2023 Dec 1;17(6):250–66.
42. Chiu CY, Miller SA. Clinical metagenomics. Nat Rev Genet. 2019 Jun 27;20(6):341–55.
43. Yu PA, Lin NH, Mahon BE, Sobel J, Yu Y, Mody RK, et al. Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin. Clinical
Infectious Diseases. 2018 Jan 1;66(suppl_1):S57–64.
44. Arnon SS, Schechter R, Maslanka SE, Jewell NP, Hatheway CL. Human Botulism Immune Globulin for the Treatment of Infant Botulism. New England Journal of Medicine. 2006 Feb
2;354(5):462–71.
45. Payne JR, Khouri JM, Jewell NP, Arnon SS. Efficacy of Human Botulism Immune Globulin for the Treatment of Infant Botulism: The First 12 Years Post Licensure. J Pediatr. 2018 Feb;193:172–
7.
46. Siegel LS. Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay. J Clin Microbiol. 1988
Nov;26(11):2351–6.
47. Centers for Disease Control and Prevention (CDC). Notice of CDC’s discontinuation of investigational pentavalent (ABCDE) botulinum toxoid vaccine for workers at risk for occupational
exposure to botulinum toxins. MMWR Morb Mortal Wkly Rep. 2011 Oct 28;60(42):1454–5.
48. Shearer JD, Manetz TS, House R V. Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B). Vaccine. 2012 Mar;30(11):1917–26.